This inventor holds 2 USPTO granted patents. Top assignee: University of Florida Research Foundation Inc.. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1999
Title: Nathan D. Griggs: Innovator in Peptide Research
Introduction
Nathan D. Griggs is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of peptide research, particularly in the development of novel peptide agonists and antagonists. With a total of 2 patents, his work has implications for immunology and therapeutic applications.
Latest Patents
Griggs' latest patents focus on superantigen agonist and antagonist peptides. The subject invention concerns novel peptide agonists and antagonists of staphylococcal enterotoxin A. Specifically exemplified are peptide agonists that stimulate T cell proliferation. This innovative approach has the potential to advance therapeutic strategies in immunology.
Career Highlights
Nathan D. Griggs is affiliated with the University of Florida Research Foundation, Incorporated. His work at this institution has allowed him to explore and develop groundbreaking research in the field of peptide science. His contributions have been recognized within the scientific community for their relevance and potential impact.
Collaborations
Griggs has collaborated with esteemed colleagues, including Howard Marcellus Johnson and Carol H. Pontzer. These collaborations have enriched his research and expanded the scope of his innovative work.
Conclusion
Nathan D. Griggs is a prominent figure in peptide research, with a focus on superantigen agonists and antagonists. His contributions to the field are significant, and his work continues to influence advancements in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile